Literature DB >> 1540411

Synthesis of human immunodeficiency virus DNA in a cell-to-cell transmission model.

P Li1, C J Burrell.   

Abstract

Cell-to-cell transmission of human immunodeficiency virus type 1 (HIV-1) was modelled by coculturing virus-infected cells with uninfected target cells at a ratio of 1:4. While H9 cells persistently infected with HTLV-IIIB did not contain unintegrated viral DNA detectable by Southern blotting, when cocultured with uninfected HUT-78 cells the mixed culture effectively underwent a new round one-step virus replication which began de novo synthesis of free viral DNA within 4 hours. Linear DNA was synthesized before the accumulation of circular DNA, and two seemingly distinct phases of viral DNA synthesis were involved. When both virus donor cells and recipient cells were arrested in the G0/G1 phase of the cell cycle, accumulation of circular viral DNA was inhibited. In contrast to cell-free virus infection of resting human peripheral blood mononuclear cells (PBMC), where no free viral DNA of discrete sizes could be detected by Southern blot, cell-to-cell transmission infection of resting PBMC resulted in the synthesis of full-length linear as well as circular viral DNA. The efficiency with which cell-to-cell transmission of HIV initiates virus replication underlines the importance of this mode of transmission in virus dissemination in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540411     DOI: 10.1089/aid.1992.8.253

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

Review 1.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA.

Authors:  N Vandegraaff; R Kumar; C J Burrell; P Li
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Establishment of persistent HIV-1 infection in vitro is accompanied by reduction of NF-kappa B activity.

Authors:  X Zhang; P Li; C J Burrell
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase.

Authors:  N Vandegraaff; R Kumar; H Hocking; T R Burke; J Mills; D Rhodes; C J Burrell; P Li
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 5.  HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy.

Authors:  Luis M Agosto; Pradeep D Uchil; Walther Mothes
Journal:  Trends Microbiol       Date:  2015-03-09       Impact factor: 17.079

6.  Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.

Authors:  D Mathez; R F Schinazi; D C Liotta; J Leibowitch
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

7.  Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells.

Authors:  G Li; M Simm; M J Potash; D J Volsky
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.

Authors:  K Zingler; D R Littman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Sterilization of HIV by gamma irradiation. A bone allograft model.

Authors:  D G Campbell; P Li; A J Stephenson; R D Oakeshott
Journal:  Int Orthop       Date:  1994-06       Impact factor: 3.075

10.  Detection of HIV-specific DNA sequences in epidermal Langerhans cells infected in vitro by means of a cell-free system.

Authors:  A S Charbonnier; F Mallet; M M Fiers; C Desgranges; C Dezutter-Dambuyant; D Schmitt
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.